Location History:
- Navarra, ES (2010)
- Pamplona-Navarra, ES (2012)
Company Filing History:
Years Active: 2010-2012
Introduction
Beatriz Moreno Bruna is a distinguished inventor based in Pamplona-Navarra, Spain. She has made significant contributions to the field of biomedicine through her innovative research and valuable patents. Her work focuses on the treatment of autoimmune diseases, specifically multiple sclerosis.
Latest Patents
Beatriz holds two notable patents that reflect her commitment to advancing medical treatments. The first patent relates to "Synergistic 5'-methylthioadenosine combinations," which involves combinations of 5'-methylthioadenosine and glatiramer acetate. This invention specifically addresses the prevention and treatment of multiple sclerosis, offering a combined preparation for simultaneous, separate, or sequential usage. The second patent focuses on the "Use of 5'-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection." This invention describes the potential of MTA and its pharmaceutically acceptable salts or prodrugs in combating autoimmune diseases, including multiple sclerosis, as well as preventing transplant rejection.
Career Highlights
Beatriz Moreno Bruna is currently associated with Proyecto de Biomedicina Cima, S.L., where her innovative research contributes to the advancement of biomedical science. Her dedication to finding effective treatments for challenging health conditions underscores her professional journey and commitment to improving patient outcomes.
Collaborations
Throughout her career, Beatriz has collaborated with esteemed colleagues such as Pablo Villoslada Díaz and Matías Antonio Ávila Zaragozá. These collaborations have fostered a supportive environment for innovation and driven significant advancements in their shared field of research.
Conclusion
In summary, Beatriz Moreno Bruna's contributions to the field of biomedicine exemplify the power of innovation in addressing critical health challenges. Her patents reflect her expertise and commitment to improving treatments for autoimmune diseases, making a significant impact on the lives of many. Through her work and collaborations, she continues to inspire future developments in the realm of medical science.